Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Barbara D. Alexander, MD, MHS

Professor of Medicine and Pathology
Duke University
Durham, NC, United States

Barbara D. Alexander, MD, MHS is Professor of Medicine and Pathology, Director of Transplant Infectious Disease (ID) Services, and Head of the Clinical Mycology Laboratory at Duke University in Durham, North Carolina. Dr Alexander is President of the Infectious Diseases Society of America (IDSA), having previously served on the Board of Directors and Chair of the Annual Meeting Program Committee. She also previously served as Associate Deputy Editor for the Clinical Infectious Diseases journal and Chair of the Clinical and Laboratory Standards Institute Subcommittee on Antifungal Tests. She currently serves as Principal Investigator for the Duke University NIH-funded T32 physician-scientist training program in Transplant ID. Her research efforts have led to standardized methods for susceptibility testing and interpretive breakpoints and epidemiologic cutoff values for fungi, FDA approval of new diagnostic tests and antifungal agents, as well as pivotal national epidemiologic investigations of fungal disease in transplant and immunocompromised host populations. She has also successfully collaborated with basic scientists to probe the molecular basis for fungal virulence and host susceptibility to invasive aspergillosis and candidemia. Dr. Alexander has lectured nationally and internationally, has authored over 185 articles, book chapters, white papers and publications for mass distribution, and is considered a thought leader in the field of transplant ID and fungal infections.

Amplyx (Individual(s) Involved: Self): Research Grant or Support; Ansun (Individual(s) Involved: Self): Research Grant or Support; Astellas Pharma (Individual(s) Involved: Self): Consultant, Grant/Research Support; Cidara (Individual(s) Involved: Self): grant to institution, Other Financial or Material Support; F2G (Individual(s) Involved: Self): grant to institution, Other Financial or Material Support; Lediant (Individual(s) Involved: Self): grant to institution, Other Financial or Material Support; SCYNEXIS, Inc. (Individual(s) Involved: Self): Consultant, Research Grant or Support; UpToDate (Individual(s) Involved: Self): Other Financial or Material Support, Royalties for chapter authorship

Presentation(s):